This is a Louisiana news story, published by Rolling Stone, that relates primarily to Jennifer Avegno news.
For more Louisiana news, you can click here:
more Louisiana newsFor more Jennifer Avegno news, you can click here:
more Jennifer Avegno newsFor more women's health news, you can click here:
more women's health newsFor more news from Rolling Stone, you can click here:
more news from Rolling StoneOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like women's health news, you might also like this article about
abortion drug. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest abortion medication news, abortion pill news, women's health news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
medication abortionRolling Stone
•67% Informative
Lawmakers in Louisiana are expected to vote Tuesday on whether to reclassify drugs used in abortion as controlled dangerous substances.
It's a move staunchly protested by hundreds of physicians in the state, who fear passing this bill will interfere with patient care given how commonly one of the pills, misoprostol, is used to save lives in pregnancy care.
Misoprostol is much more than an abortion pill.
The bill has spurred an outcry from reproductive health advocates across the country.
Reproductive health advocates worry that consequences could reverberate across states with restrictive abortion access.
Louisiana is already one of the states with the worst maternal mortality rates.
Dr. Jennifer Avegno is the director of New Orleans ’ health department.
She says mischaracterizing misoprostol and mifepristone as “dangerous” is “bad science,” and none of her colleagues or the 280 health care professionals who signed the letter have identified any case of the drugs being abused like other Schedule IV drugs like Xanax and Valium.
Freehill and fellow doctors are worried that patients will be confused about the medication in general.
VR Score
53
Informative language
42
Neutral language
45
Article tone
informal
Language
English
Language complexity
60
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
9
Source diversity
7
Affiliate links
no affiliate links